Demcizumab (Anti-DLL4)
Product Specifications
CAS Number
1243262-17-0
Synonyms
OMP 21M18; Human Anti-TNFRSF10B Recombinant Antibody
Additionnal Information
Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470040-500 1x 500 µL
CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740225-100 1x 100 µL
Major Vault Protein (MVP) (1032), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470040-100 1x 100 µL
CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741387-500 1x 500 µL
Ferritin, Light Chain (FTL) (Microglia Marker) (FTL/1387), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472829-500 1x 500 µL
Golgi Complex (Marker for Human Cells) (GLG1/2829R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940968-100 1x 100 µL
CD63 (LAMP3/968), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details